HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,806 Cr | ₹2,764 Cr | ₹2,385 Cr | ₹2,328 Cr | ₹2,016 Cr |
What is the latest Total Liabilities ratio of HIKAL ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,806 Cr |
| Mar2024 | ₹2,764 Cr |
| Mar2023 | ₹2,385 Cr |
| Mar2022 | ₹2,328 Cr |
| Mar2021 | ₹2,016 Cr |
How is Total Liabilities of HIKAL Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,806 Cr | 1.55 | |
| Mar2024 | ₹2,764 Cr | 15.85 | |
| Mar2023 | ₹2,385 Cr | 2.47 | |
| Mar2022 | ₹2,328 Cr | 15.49 | |
| Mar2021 | ₹2,016 Cr | - | |
Compare Total Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,584.4 Cr | -2.7% | -13.7% | -39.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.7% |
-13.7% |
-39.2% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses